Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Bours

Showing results (71-80 of 199) with videos related to

Pageof 20
Sort By:
Molecular Endocrinology (Baltimore, Md.)|June 7, 2003
The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaBSebastien P Tabruyn, Catherine M Sorlet, Francoise Rentier-Delrue, et al.
Scientific Reports|February 5, 2021
Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapyPablo Beckers, Jean-Hubert Caberg, Vinciane Dideberg, et al.
Clinical Kidney Journal|April 9, 2015
Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosisOriane Hanssen, Emilie Castermans, Christophe Bovy, et al.
Oncogene|January 16, 2003
NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cellsMohamed Bentires-Alj, Veronique Barbu, Marianne Fillet, et al.
International Journal of Oncology|December 5, 2006
Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomasPierre A Robe, Minh-Tuan Nguyen-Khac, Frederic Lambert, et al.
Molecular Genetics & Genomic Medicine|September 22, 2020
Screening of germline mutations in young Rwandan patients with breast cancersJeanne P Uyisenga, Karin Segers, Aimé Z Lumaka, et al.
Clinical Biochemistry|October 27, 2015
Identification and frequencies of cystic fibrosis mutations in central ArgentinaXavier Pepermans, Soledad Mellado, Sergio Chialina, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|July 18, 2013
Modulating effect of COMT genotype on the brain regions underlying proactive control process during inhibitionMathieu Jaspar, Sarah Genon, Vincenzo Muto, et al.
Cells|November 27, 2024
Non-Immune-Mediated, p27-Associated, Growth Inhibition of Glioblastoma by Class-II-Transactivator (CIITA)A Katherine Tan, Aurelie Henry, Nicolas Goffart, et al.
Current Medicinal Chemistry|April 8, 2003
NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targetsAlain Chariot, Marie-Alice Meuwis, Marianne Bonif, et al.
Pageof 20

Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
Molecular Endocrinology (Baltimore, Md.)|June 7, 2003
The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaBSebastien P Tabruyn, Catherine M Sorlet, Francoise Rentier-Delrue, et al.
Scientific Reports|February 5, 2021
Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapyPablo Beckers, Jean-Hubert Caberg, Vinciane Dideberg, et al.
Clinical Kidney Journal|April 9, 2015
Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosisOriane Hanssen, Emilie Castermans, Christophe Bovy, et al.
Oncogene|January 16, 2003
NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cellsMohamed Bentires-Alj, Veronique Barbu, Marianne Fillet, et al.
International Journal of Oncology|December 5, 2006
Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomasPierre A Robe, Minh-Tuan Nguyen-Khac, Frederic Lambert, et al.
Molecular Genetics & Genomic Medicine|September 22, 2020
Screening of germline mutations in young Rwandan patients with breast cancersJeanne P Uyisenga, Karin Segers, Aimé Z Lumaka, et al.
Clinical Biochemistry|October 27, 2015
Identification and frequencies of cystic fibrosis mutations in central ArgentinaXavier Pepermans, Soledad Mellado, Sergio Chialina, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|July 18, 2013
Modulating effect of COMT genotype on the brain regions underlying proactive control process during inhibitionMathieu Jaspar, Sarah Genon, Vincenzo Muto, et al.
Cells|November 27, 2024
Non-Immune-Mediated, p27-Associated, Growth Inhibition of Glioblastoma by Class-II-Transactivator (CIITA)A Katherine Tan, Aurelie Henry, Nicolas Goffart, et al.
Current Medicinal Chemistry|April 8, 2003
NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targetsAlain Chariot, Marie-Alice Meuwis, Marianne Bonif, et al.
Pageof 20